1
250
X. Song, R. I. Hollingsworth
LETTER
5
-O-Methanesulfonyl-2,3,4,6-tetra-O-pivaloyl-D-gluconitrile (3):
5-O-Methanesulfonyl-2,3,4,6-tetra-O-acetyl-D-gluconitrile (22):
[a]D +28.1 (c 1.8, CHCl3); HRMS–FAB: m/z calcd for
[
a]D +29.08 (c 0.8, CHCl ). HRMS–FAB: m/z calcd for
3
+
1
+
1
C H NO S: 591.2713; found: 592.2789 [MH ]. H NMR (500
C H NO S: 423.0835; found: 424.0911 [MH ]. H NMR (500
2
7
45
11
15 21 11
MHz, CDCl ): d = 1.24, 1.27, 1.29, 1.30 (4 × 9 H, 4 × s), 3.12 (3 H,
MHz, CDCl ): d = 2.13, 2.19, 2.23, 2.24, (4 × 3 H, 4 × s), 3.11 (3 H,
3
3
s), 4.12 (1 H, dd, J5 = 4.6 Hz, J = 13.0 Hz, H-6¢), 4.52 (1 H, dd,
s), 4.26 (1 H, dd, J = 5.6 Hz, J = 12.8 Hz, H-6¢), 4.41 (1 H, dd,
,6¢
6,6¢
5,6¢
6,6¢
J5,6 = 2.6 Hz, H-6), 4.93 (1 H, ddd, J4,5 = 7.5 Hz, H-5), 5.42 (1 H,
J5,6 = 2.8 Hz, H-6), 5.04 (1 H, ddd, J4,5 = 8.0 Hz, H-5), 5.34 (1 H,
dd, J2,3 = 7.0 Hz, J = 2.4 Hz, H-3), 5.61 (1 H, d, H-2), 5.70 (1 H,
dd, J2,3 = 6.4 Hz, J = 2.3 Hz, H-3), 5.61 (1 H, dd, H-4), 5.66 (1 H,
3,4
3,4
dd, H-4). 13C NMR (125 MHz, CDCl ): d = 26.76, 27.00, 27.04,
d, H-2). C NMR (125 MHz, CDCl ): d = 20.04, 20.45, 20.58,
13
3
3
3
1
1
8.89, 38.91, 39.08, 39.11, 39.21, 58.65, 61.23, 66.51, 67.08, 74.88,
13.94, 175.75, 176.38, 176.64, 177.82. IR: 2362, 2342, 1746,
481, 1368, 1218 cm .
20.62, 38.78, 58.23, 61.53, 66.49, 67.00, 74.50, 113.93, 167.99,
–
1
169.30, 169.70, 170.17. IR: 2362, 2340, 1756, 1372, 1216 cm .
–1
5
-O-Methanesulfonyl-2,3,4,6-tetra-O-pivaloyl-D-mannonitrile
Acknowledgment
1
(
1
13): [a] +0.95 (c 0.3, CHCl ). H NMR (500 MHz, CDCl ): d =
D
3
3
.18, 1.21, 1.22, 1.28 (4 × 9 H, 4 × s), 3.11 (3 H, s), 4.09 (1 H, dd,
This research was supported by a Strategic Grant from the Michigan
State University Foundation and by the Michigan State University
Research Excellence Fund.
J5,6¢ = 4.1 Hz, J = 13.1 Hz, H-6¢), 4.43 (1 H, dd, J = 2.4 Hz, H-
6
2
6,6¢
5,6
), 4.84 (1 H, ddd, J4,5 = 8.1 Hz, H-5), 5.30 (1 H, d, J = 7.3 Hz, H-
2,3
1
3
), 5.39 (1 H, dd, J3,4 = 2.0 Hz, H-4), 5.42 (1 H, dd, H-3). C NMR
(
3
1
125 MHz, CDCl ): d = 26.71, 26.91, 26.93, 27.00, 38.81, 39.04,
3
9.10, 39.13, 59.3, 61.41, 66.51, 67.23, 74.48, 114.29, 175.66, References
–1
76.45, 176.52, 177.63. IR: 2363, 2344, 1744, 1215 cm .
(
1) Essentials of Glycobiology; Varki, A.; Cummings, R.; Esko,
J.; Freeze, H.; Hart, G.; Marth, J., Eds.; Cold Spring Harbor:
New York, 1999, 653.
5
(
-O-Methanesulfonyl-2,3,4,6-tetra-O-pivaloyl-D-galactonitrile
1
14): H NMR (500 MHz, CDCl ): d = 1.17, 1.19, 1.23, 1.28 (4 × 9
3
H, 4 × s), 3.15 (3 H, s), 4.08 (1 H, dd, J = 7.0 Hz, J = 11.9 Hz,
(2) (a) Gumina, G.; Chong, Y.; Choo, H.; Song, G.; Chu, C. K.
Curr. Top. Med. Chem. 2002, 2, 1065. (b) Wang, P.; Hong,
J. H.; Cooperwood, J. S.; Chu, C. K. Antivir. Res. 1998, 40,
19. (c) Ashley, G. W. J. Am. Chem. Soc. 1992, 114, 9731.
(d) Mansuri, M. M.; Farina, V.; Starrett, J. E. Jr.; Benigni, D.
A.; Brankovan, V.; Martin, J. C. Bioorg. Med. Chem. Lett.
1991, 1, 65.
5
,6¢
6,6¢
H-6¢), 4.16 (1 H, dd, J = 5.8 Hz, H-6), 4.92 (1 H, ddd, J4,5 = 1.8
5
,6
Hz, H-5), 5.34 (1 H, d, J2,3 = 2.3 Hz, H-2), 5.36 (1 H, dd, J = 9.6
3,4
1
3
Hz, H-4), 5.63 (1 H, dd, H-3). C NMR (125 MHz, CDCl ): d =
2
6
3
6.68, 26.85, 26.90, 26.95, 38.72, 38.80, 38,96, 39.04, 39.08, 58.99,
1.86, 66.10, 66.76, 74.72, 114.00, 175.84, 176.10, 176.32, 177.62.
–
1
IR: 2363, 2344, 1744, 1482, 1366, 1216 cm .
(
3) (a) Takahashi, H.; Hitomi, Y.; Iwai, Y.; Ikegami, S. J. Am.
Chem. Soc. 2000, 122, 2995. (b) Takahashi, H.; Iwai, Y.;
Hitomi, Y.; Ikegami, S. Org. Lett. 2002, 4, 2401.
4) Lee, S. J.; Seo, M. J.; Jeong, N. C.; Kim, G. C.; Hong, H. W.;
Kim, S. A. US 6,448,415, 2002.
4
+
1
-O-Methanesulfonyl-2,3,5-tri-O-pivaloyl-D-ribonitrile (15): [a]
D
1
24.2 (c 2.4, CHCl ). H NMR (500 MHz, CDCl ): d = 1.23, 1.24,
3
3
.26 (3 × 9 H, 3 × s), 3.18 (3 H, s), 4.21 (1 H, dd, J = 4.6 Hz,
4
,5¢
(
J5,5¢ = 12.9 Hz, H-5¢), 4.53 (1 H, dd, J = 3.1 Hz, H-5), 5.12 (1 H,
4,5
ddd, J3,4 = 6.7 Hz, H-4), 5.43 (1 H, dd, J = 3.3 Hz, H-3), 5.79
2,3
(
3
1
1 H, d, H-2). 13C NMR (125 MHz, CDCl ): d = 26.76, 26.84, 27.01,
(5) Acton, E. M.; Ryan, K. J.; Goodman, L. J. Am. Chem. Soc.
964, 86, 5352.
(6) Haas, J. W. Jr.; Kadunce, R. E. J. Am. Chem. Soc. 1962, 84,
910.
3
1
8.88, 38.91, 39.02, 60.55, 61.44, 68.17, 74.64, 113.75, 175.82,
–
1
76.02, 177.64. IR: 2363, 2344, 1748, 1482, 1367, 1215 cm .
4
(
(
7) Hicks, A.; Fraser-Reid, B. Can. J. Chem. 1974, 52, 3367.
8) Angelotti, T.; Krisko, M.; O’Connor, T.; Serianni, A. S. J.
Am. Chem. Soc. 1987, 109, 4464.
Preparation of L-idono-1,4-lactone from b-D-glucose-penta-
acetate
It is essentially the same as the procedure described above except fi-
nal hydrolysis step. 5-O-Methanesulfonyl-2,3,4,6-tetra-O-acetyl-D-
gluconitrile (22) was first refluxed in MeCN–H O (4:1) for 12 h and
2
then evaporated, the residue was refluxed in 2 N HCl in 1:1 mixture
of EtOH and H O for 1 h to give L-idono-1,4-lactone.
2
Synlett 2007, No. 8, 1247–1250 © Thieme Stuttgart · New York